Medicus Pharma Ltd.
MDCX.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.58M | 3.12M | 1.06M | 2.20M | 2.28M |
| Depreciation & Amortization | -- | -- | -78.40K | 26.30K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.02M | 5.13M | 2.35M | 3.01M | 3.55M |
| Operating Income | -6.02M | -5.13M | -2.35M | -3.01M | -3.55M |
| Income Before Tax | -6.18M | -5.10M | -2.27M | -2.96M | -3.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.18M | -5.10M | -2.27M | -2.96M | -3.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.18M | -5.10M | -2.27M | -2.96M | -3.63M |
| EBIT | -6.02M | -5.13M | -2.35M | -3.01M | -3.55M |
| EBITDA | -- | -- | -2.32M | -2.98M | -3.53M |
| EPS Basic | -0.43 | -0.42 | -0.20 | -0.31 | -0.44 |
| Normalized Basic EPS | -0.27 | -0.26 | -0.13 | -0.19 | -0.28 |
| EPS Diluted | -0.43 | -0.84 | -0.20 | -0.31 | -0.44 |
| Normalized Diluted EPS | -0.27 | -0.26 | -0.13 | -0.19 | -0.28 |
| Average Basic Shares Outstanding | 14.28M | 12.24M | 11.37M | 9.51M | 8.17M |
| Average Diluted Shares Outstanding | 14.28M | 12.24M | 11.37M | 9.51M | 8.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |